Habib J. Dable, CEO and President at ACCELERON PHARMA INC (XLRN), sold 92,200 shares at $99.42 ($8.9M) on 2020-07-01, disclosed to the SEC on 2020-07-06.
Open-market sale of $8.9M XLRN by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.53 | 3,700 | $346K | 3.9% |
| 2 | $94.46 | 3,000 | $283K | 3.2% |
| 3 | $95.85 | 13,047 | $1.3M | 14.0% |
| 4 | $95.85 | 13,047 | $1.3M | 14.0% |
| 5 | $96.49 | 15,219 | $1.5M | 16.5% |
| 6 | $96.49 | 15,219 |
| $1.5M |
| 16.5% |
| 7 | $97.43 | 9,534 | $929K | 10.4% |
| 8 | $97.43 | 9,534 | $929K | 10.4% |
| 9 | $98.57 | 4,400 | $434K | 4.9% |
| 10 | $98.57 | 4,400 | $434K | 4.9% |
| 11 | $99.42 | 1,100 | $109K | 1.2% |
| Total | $96.55 avg | 92,200 | $8.9M | 100% |
| Filing → |
| XLRN | SELL | 2020-01-03 | $377K | — | Filing → |
| XLRN | SELL | 2019-09-10 | $493K | — | Filing → |
| XLRN | SELL | 2019-04-11 | $654K | — | Filing → |